Your browser doesn't support javascript.
loading
LAIR-1 agonism as a therapy for acute myeloid leukemia.
Lovewell, Rustin R; Hong, Junshik; Kundu, Subhadip; Fielder, Carly M; Hu, Qianni; Kim, Kwang Woon; Ramsey, Haley E; Gorska, Agnieszka E; Fuller, Londa S; Tian, Linjie; Kothari, Priyanka; Paucarmayta, Ana; Mason, Emily F; Meza, Ingrid; Manzanarez, Yanira; Bosiacki, Jason; Maloveste, Karla; Mitchell, Ngan; Barbu, Emilia A; Morawski, Aaron; Maloveste, Sebastien; Cusumano, Zac; Patel, Shashank J; Savona, Michael R; Langermann, Solomon; Myint, Han; Flies, Dallas B; Kim, Tae Kon.
Afiliação
  • Lovewell RR; NextCure Inc., Beltsville, Maryland, USA.
  • Hong J; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Kundu S; Seoul National University Hospital and.
  • Fielder CM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
  • Hu Q; NextCure Inc., Beltsville, Maryland, USA.
  • Kim KW; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Ramsey HE; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Gorska AE; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Fuller LS; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Tian L; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Kothari P; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Paucarmayta A; NextCure Inc., Beltsville, Maryland, USA.
  • Mason EF; NextCure Inc., Beltsville, Maryland, USA.
  • Meza I; NextCure Inc., Beltsville, Maryland, USA.
  • Manzanarez Y; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center.
  • Bosiacki J; NextCure Inc., Beltsville, Maryland, USA.
  • Maloveste K; NextCure Inc., Beltsville, Maryland, USA.
  • Mitchell N; NextCure Inc., Beltsville, Maryland, USA.
  • Barbu EA; NextCure Inc., Beltsville, Maryland, USA.
  • Morawski A; NextCure Inc., Beltsville, Maryland, USA.
  • Maloveste S; NextCure Inc., Beltsville, Maryland, USA.
  • Cusumano Z; NextCure Inc., Beltsville, Maryland, USA.
  • Patel SJ; NextCure Inc., Beltsville, Maryland, USA.
  • Savona MR; NextCure Inc., Beltsville, Maryland, USA.
  • Langermann S; NextCure Inc., Beltsville, Maryland, USA.
  • Myint H; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Flies DB; Vanderbilt Center for Immunobiology.
  • Kim TK; Vanderbilt-Ingram Cancer Center, and.
J Clin Invest ; 133(22)2023 11 15.
Article em En | MEDLINE | ID: mdl-37966113
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Limite: Animals / Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Limite: Animals / Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos